Adelene Q. Perkins
2019
In 2019, Adelene Q. Perkins earned a total compensation of $1.7M as Chief Executive Officer at Infinity Pharmaceuticals.
Compensation breakdown
| Bonus | $61,250 |
|---|---|
| Non-Equity Incentive Plan | $366,370 |
| Option Awards | $552,480 |
| Salary | $689,585 |
| Other | $11,172 |
| Total | $1,680,857 |
Perkins received $689.6K in salary, accounting for 41% of the total pay in 2019.
Perkins also received $61.3K in bonus, $366.4K in non-equity incentive plan, $552.5K in option awards and $11.2K in other compensation.
Rankings
In 2019, Adelene Q. Perkins' compensation ranked 6,762nd out of 13,971 executives tracked by ExecPay. In other words, Perkins earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,762 out of 13,971 | 52nd |
Division Manufacturing | 2,581 out of 5,701 | 55th |
Major group Chemicals And Allied Products | 946 out of 2,200 | 57th |
Industry group Drugs | 800 out of 1,886 | 58th |
Industry Pharmaceutical Preparations | 585 out of 1,398 | 58th |
Source: SEC filing on April 26, 2021.
Perkins' colleagues
We found two more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2019.